Neuroserpin: A Potential Neuroprotective Agent in Mild Neonatal Hypoxic–Ischaemic Encephalopathy
Cells · 2025
DOI: 10.3390/cells14231840 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Eri Kawashita und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Anatomy and Genetics, University of Oxford, Sherrington Building, Sherrington Rd, Oxford OX1 3PT, UK. Hauptthemen laut MEDLINE: Hypoxia-Ischemia, Brain, Neuroserpin, Neuroprotective Agents, Serpins. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Society, Department of Science and Technology of Guangdong Province, Uehara Memorial Foundation.
Abstract (Originalsprache)
Neonatal hypoxic–ischaemic encephalopathy (HIE) remains a leading cause of infant morbidity and mortality worldwide, with therapeutic hypothermia being the only clinically approved treatment. This study investigates the cortical expression pattern of neuroserpin during postnatal brain development and evaluates its neuroprotective potential in hypoxia–ischaemia (HI)-induced brain damage using a modified Rice–Vannucci model. Experiments were conducted in both male and female neuroserpin knockout (KO) mice and through administration of exogenous neuroserpin into the brain. Between postnatal day 4 to 14 (P4–P14), neuroserpin-immunoreactive cell density peaked at P8–P10 in cortical layers 5 and 6b, with a gradual increase in layers 2/3 and minimal changes in layers 4 and 6a. Despite comparable levels of ischaemic brain damage between the KO and wild-type (WT) mice, exogenous neuroserpin administration suppressed the HI-induced oxidative stress. Additionally, it reduced microglial activation and reactive astrogliosis in the cortex in mild HIE, mitigating cortical thinning and preserving neuronal distribution. These findings suggest that endogenous neuroserpin alone is insufficient for neuroprotection against HI-induced damage, but exogenous neuroserpin shows promise as a pharmacological intervention for mild neonatal HIE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Anatomy and Genetics, University of Oxford, Sherrington Building, Sherrington Rd, Oxford OX1 3PT, UK.
- Laboratory of Pathological Biochemistry, Kyoto Pharmaceutical University, Misasagi Nakauchi-cho, Yamashina-ku, Kyoto 607-8414, Japan.
- Department of Neurology, University of California, San Francisco, Sandler Neuroscience Building, 675 Nelson Rising Lane, San Francisco, CA 94158, USA.
- JNU-HKUST Joint Laboratory for Neuroscience and Innovative Drug Research, College of Pharmacy, Jinan University, Guangzhou 510632, China.
ORCID-Profile: Peiyun Zhong, Anna Hoerder-Suabedissen, Luana Campos Soares, Zoltán Molnár
Förderung
- Royal Society
- Department of Science and Technology of Guangdong Province
- Uehara Memorial Foundation
- Japan Society for the Promotion of Science
- Takeda Science Foundation
- Biotechnology and Biological Sciences Research Council
- Medical Research Council
- Einstein Foundation
Zitieren
APA
Kawashita, E., Fukuzaki, Y., Fischer, J., Shi, L., Liao, Y., Millar, L. J., Zhong, P., Hoerder-Suabedissen, A., Soares, L. C., & Molnár, Z. (2025). Neuroserpin: A Potential Neuroprotective Agent in Mild Neonatal Hypoxic–Ischaemic Encephalopathy. Cells. https://doi.org/10.3390/cells14231840
Vancouver
Kawashita E, Fukuzaki Y, Fischer J, Shi L, Liao Y, Millar LJ, et al. Neuroserpin: A Potential Neuroprotective Agent in Mild Neonatal Hypoxic–Ischaemic Encephalopathy. Cells. 2025. doi:10.3390/cells14231840
BibTeX
@article{Kawashita2025,
author = {Kawashita, Eri and Fukuzaki, Yumi and Fischer, Jan and Shi, Lei and Liao, Yumei and Millar, Lancelot Jamie and Zhong, Peiyun and Hoerder-Suabedissen, Anna and Soares, Luana Campos and Molnár, Zoltán},
title = {Neuroserpin: A Potential Neuroprotective Agent in Mild Neonatal Hypoxic–Ischaemic Encephalopathy},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14231840}
}
EUVIMED